Endothelial dysfunction limits the antihypertrophic action of Bradykinin in rat cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 6, 2000, Pages 1119-1126

  Rosenkranz, Anke C ^a   Dusting, Gregory J ^a   Ritchie, Rebecca H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bradykinin; Cardiomyocytes; Endothelial cells; Hyperglycemia; Hypertrophy

Indexed keywords

ANGIOTENSIN; BRADYKININ; CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ANIMALIA; BOVINAE;

EID: 0033845420     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1149     Document Type: Article

References (35)

1. Biochemical mechanisms of cardiac hypertrophy
2. Left ventricular hypertrophy and mortality in hypertension: An analysis of data from the Glasgow Blood Pressure clinic
3. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies
4. Tissue angiotensin II system in the human heart
5. Contribution of bradykinin to the cardiovascular effects of ramipril
6. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes
7. Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells
8. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide
9. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
10. Nitric oxide: Physiology, pathophysiology, and pharmacology
11. Nitric oxide in cardiovascular disorders
12. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation
13. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia
14. Impairment of endothelium-dependent but not of endothelium-independent dilatation in guinea-pig aorta rings incubated in the presence of elevated glucose
15. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits
16. Myocardial disease in hypertensive-diabetic patients
17. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)
18. Cardiac hypertrophy in diabetic spontaneously hypertensive rats: Role of angiotensin II?
19. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture
20. Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes
21. - vascular smooth muscle cells
22. The action of oxidised low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes
23. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
24. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin I receptors
25. Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions
26. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha
27. Inhibition of endothelial nitric oxide synthase activity by protein kinase C
28. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner
29. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
30. Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia
31. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
32. Myocardial and endothelial dysfunction after multiple, brief coronary occlusions: Role of oxygen radicals
33. Native and oxidised low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
34. Inactivation of endothelial-derived relaxing factor by oxidised LDL
35. Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide